Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Cyclooxygenase-2 Inhibitors and Cancer (Guest Editor: J.-P. Henichart)] promotion: free to download

Volume:6   Issue:3
Pp: 185-185
Jean-Pierre Henichart
DOI: 10.2174/187152006776930837

Mechanisms Leading to COX-2 Expression and COX-2 Induced Tumorigenesis: Topical Therapeutic Strategies Targeting COX-2 Expression and Activity

Volume:6   Issue:3
Pp: 187-208
Aurelie Telliez, Christophe Furman, Nicole Pommery and Jean-Pierre Henichart
DOI: 10.2174/187152006776930891

The Potential and Rationale for COX-2 Inhibitors in Lung Cancer

Volume:6   Issue:3
Pp: 209-220
Kostyantyn Krysan, Karen L. Reckamp, Sherven Sharma and Steven M. Dubinett
DOI: 10.2174/187152006776930882

The Use of Nimesulide and Its Analogues in Cancer Chemoprevention

Volume:6   Issue:3
Pp: 233-237
Jean-Francois Renard, Fabien Julemont, Xavier d. Leval and Bernard Pirotte
DOI: 10.2174/187152006776930855

A Computational View of COX-2 Inhibition

Volume:6   Issue:3
Pp: 239-249
Philippe Chavatte and Amaury Farce
DOI: 10.2174/187152006776930909

Promotion of Optimized Protein Therapy by Bioconjugation as a Polymeric DDS

Volume:6   Issue:3
Pp: 251-258
Yasuhiro Abe, Hiroko Shibata, Haruhiko Kamada, Shin-Ichi Tsunoda, Yasuo Tsutsumi and Shinsaku Nakagawa
DOI: 10.2174/187152006776930864

Betulinic Acid Derivatives as Anticancer Agents: Structure Activity Relationship

Volume:6   Issue:3
Pp: 271-279
Rama Mukherjee, Vivek Kumar, Sanjay K. Srivastava, Shiv K. Agarwal and Anand C. Burman
DOI: 10.2174/187152006776930846